MétaCan
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

This cohort has 4,299,418 works, more than the 100,000-row export cap: the file will contain the first 100,000 ordered by OpenAlex id, and says so in its last line. Narrow the cohort, page the API, or rebuild the frame from the repository for the rest. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
→
Sort
Language
Type
Field
Venue
Topic
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

4,299,418 results · 0 filters active
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
4,299,418 works in the cohort · of 4,299,418page 1,259 of 85,989

Labels cover 11,048 of 4,299,418 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 4,299,418 of 4,299,418 works in this cohort. Predictions are machine_predicted_unvalidated. The Gemma side is a direct model label for every work (title-only); the Codex side is a distilled, calibrated classifier. Candidate is the union; consensus is the intersection.

affunlabeled
Efficacy and Safety of Ixekizumab in the Treatment of Radiographic Axial Spondyloarthritis: Sixteen‐Week Results From a Phase <scp>III</scp> Randomized, Double‐Blind, Placebo‐Controlled Trial in Patients With Prior Inadequate Response to or Intolerance of Tumor Necrosis Factor Inhibitors
Atul Deodhar, Denis Poddubnyy, César Pacheco‐Tena, Carlo Salvarani, Éric Lespessailles, Proton Rahman +10 more
2018· article· en· Arthritis & Rheumatology· Medicine
machine prediction:candidate · noneconsensus · none
233
citations
affunlabeled
Targeting Prodromal Alzheimer Disease With Avagacestat
Vladimir Coric, Stephen Salloway, Christopher H. van Dyck, Bruno Dubois, Niels Andreasen, Mark Brody +22 more
2015· article· en· JAMA Neurology· Medicine
machine prediction:candidate · noneconsensus · none
233
citations
affunlabeled
Specificity and Denaturing of Small Business
Olivier Torrès, Pierre‐André Julien
2005· article· en· International Small Business Journal Researching Entrepreneurship· Business, Management and Accounting
machine prediction:candidate · noneconsensus · none
233
citations
afffundunlabeled
Measurements of Higgs boson production and couplings in the four-lepton channel in<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" display="inline"><mml:mrow><mml:mi>p</mml:mi><mml:mi>p</mml:mi></mml:mrow></mml:math>collisions at center-of-mass energies of 7 and 8 TeV with the ATLAS detector
G. Aad, B. Abbott, J. Abdallah, S. Abdel Khalek, O. Abdinov, R. Aben +2833 more
2015· article· en· Physical review. D. Particles, fields, gravitation, and cosmology/Physical review. D, Particles, fields, gravitation, and cosmology· Physics and Astronomy
machine prediction:candidate · noneconsensus · none
233
citations

How this was built: Screen · Findings · About